Related references
Note: Only part of the references are listed.The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways
Svitlana Demyanets et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Phenotypic heterogeneity of the endothelium II. Representative vascular beds
William C. Aird
CIRCULATION RESEARCH (2007)
Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro
E. Ben-Tal Cohen et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Angiopoietins: a link between angiogenesis and inflammation
Ulrike Fiedler et al.
TRENDS IN IMMUNOLOGY (2006)
Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures
Ursula Fearon et al.
ARTHRITIS AND RHEUMATISM (2006)
Signaling and functions of angiopoietin-1 in vascular protection
NPJ Brindle et al.
CIRCULATION RESEARCH (2006)
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
L Eklund et al.
EXPERIMENTAL CELL RESEARCH (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Oncostatin M causes VEGF release from human airway smooth muscle:: synergy with IL-1β
DS Faffe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor
SK Lin et al.
ARTHRITIS AND RHEUMATISM (2004)
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure
AY Chong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor Tie-2, and vascular endothelial growth factor levels in acute coronary syndromes
KW Lee et al.
CIRCULATION (2004)
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Paladebodies
U Fiedler et al.
BLOOD (2004)
Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat
R Sandhu et al.
CARDIOVASCULAR RESEARCH (2004)
Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells
P Repovic et al.
ONCOGENE (2003)
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes
TW Weiss et al.
CARDIOVASCULAR RESEARCH (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3
K Mahboubi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
M Autiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
LH Wei et al.
ONCOGENE (2003)
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
IB Lobov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
STAT1 and STAT3 mediate thrombin-induced expression of TIMP-1 in human glomerular mesangial cells
XM Chen et al.
KIDNEY INTERNATIONAL (2002)
Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms
F Blanchard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
HG Eiken et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
Share Paper
